Therapeutic catheterization in congenital heart disease: reflections on the value of risk scores

Anselm Uebing^{1

2}, Michael A Gatzoulis^{1

2}, Michael L Rigby^{2

3}

Affiliations

¹ Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, UK.
² National Heart and Lung Institute, Imperial College School of Medicine, London, UK.
³ Department of Paediatric Cardiology, Royal Brompton Hospital, London, UK.

Editorial

Anselm Uebing et al. Eur Heart J. 2017.

. 2017 Jul 7;38(26):2077-2078.

doi: 10.1093/eurheartj/ehx299.

Anselm Uebing^{1

2}, Michael A Gatzoulis^{1

2}, Michael L Rigby^{2

3}

¹ Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, UK.
² National Heart and Lung Institute, Imperial College School of Medicine, London, UK.
³ Department of Paediatric Cardiology, Royal Brompton Hospital, London, UK.

No abstract available

Comment on

Prediction of adverse events after catheter-based procedures in adolescents and adults with congenital heart disease in the IMPACT registry.
Stefanescu Schmidt AC, Armstrong A, Kennedy KF, Nykanen D, Aboulhosn J, Bhatt AB. Stefanescu Schmidt AC, et al. Eur Heart J. 2017 Jul 7;38(26):2070-2077. doi: 10.1093/eurheartj/ehx200. Eur Heart J. 2017. PMID: 28430913 Free PMC article.